Bank of America: Raises Eli Lilly’s price target to $1,334

Golden Finance reported that on July 10, Bank of America Global Research raised Eli Lilly’s target price from $1,251 to $1,334.
LLY-2.33%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned